Blumio is a medical technology company at the forefront of developing a novel sensor technology for continuous, non-invasive, and cuffless blood pressure monitoring. Their mission is to transform cardiovascular health management by providing accessible and accurate biometric data. Blumio's technology aims to integrate into various devices, from medical wearables to consumer electronics, enabling users and healthcare providers to better understand and manage blood pressure trends. They are focused on addressing the global challenge of hypertension by making blood pressure monitoring more convenient and proactive.
Serves as the primary center for research and development, engineering, product development, and corporate operations.
Modern office and lab space designed to foster innovation and collaboration, equipped for advanced sensor technology research and development.
A dynamic, agile, and innovative work environment characteristic of Silicon Valley tech startups. Emphasis on collaboration, cutting-edge research, and a mission-driven approach to improving healthcare. Employees often engage in a fast-paced setting with opportunities for significant impact in medical technology.
Strategically located in Silicon Valley, providing Blumio with access to a rich ecosystem of tech talent, research institutions, potential partners, and venture capital, which is crucial for a medical device and sensor technology company.
Blumio is primarily based in the United States, with its research, development, and core operations centered in Silicon Valley. While their physical presence is concentrated, their technology and potential partnerships aim for a global impact in the medical device and wearable technology markets. They seek to address a worldwide health concern with solutions that can be integrated into products distributed internationally.
[Information not publicly available, typically PO Boxes or private addresses for startups]
Sunnyvale
California
United States
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Blumio (acquired by Cardiex)' leadership includes:
Blumio (acquired by Cardiex) has been backed by several prominent investors over the years, including:
Blumio's executive leadership has remained consistent over the past 12 months, focusing on advancing their technology and strategic goals. No major public announcements regarding executive hires or departures have been identified during this period.
Discover the tools Blumio (acquired by Cardiex) uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Blumio likely uses standard professional email address formats common in the tech industry. These formats typically combine employee names with the company domain.
[first].[last]@blumio.com
Format
catherine.liao@blumio.com
Example
85%
Success rate
Business Wire • February 27, 2023
Blumio announced a partnership with Valencell to combine Blumio's radar-based sensor technology with Valencell's PPG sensor expertise to deliver cuffless blood pressure solutions for wearables and hearables....more
PR Newswire • January 18, 2023
Blumio's wearable cardiovascular sensor technology received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA), highlighting its potential to provide a more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions....more
MobiHealthNews • October 26, 2022
Blumio announced an extension to its seed funding round, bringing the total to $6.5 million. The funding is aimed at furthering the development and validation of its radar-based sensor for cuffless blood pressure monitoring....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Blumio (acquired by Cardiex), are just a search away.